<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>3D printing</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>US, European biotechs lead budding organ-on-a-chip market</title>
      <description>
        <![CDATA[U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, fueled by the U.S. FDA’s decision to phase out animal testing for investigational new drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726519</guid>
      <pubDate>Thu, 20 Nov 2025 07:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726519-us-european-biotechs-lead-budding-organ-on-a-chip-market</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Emulate-Chip-R1-Brain-19nov25.webp?t=1763590564" type="image/jpeg" medium="image" fileSize="322160">
        <media:title type="plain">Emulate Chip R1 Brain</media:title>
        <media:description type="plain">Emulate Brain-Chip R1 integrates FCDI iCell products co-cultured with Emulate's induced brain microvascular endothelial cells, providing a platform that models the complexities of the human brain. Credit: Emulate</media:description>
      </media:content>
    </item>
    <item>
      <title>US, European biotechs lead budding organ-on-a-chip market</title>
      <description>
        <![CDATA[U.S. and European organ-on-a-chip specialty biotechnology companies are driving development of organ-on-a-chip technologies, fueled by the U.S. FDA’s decision to phase out animal testing for investigational new drugs.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726207</guid>
      <pubDate>Wed, 19 Nov 2025 07:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726207-us-european-biotechs-lead-budding-organ-on-a-chip-market</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Emulate-Chip-R1-Brain-19nov25.webp?t=1763590564" type="image/jpeg" medium="image" fileSize="322160">
        <media:title type="plain">Emulate Chip R1 Brain</media:title>
        <media:description type="plain">Emulate Brain-Chip R1 integrates FCDI iCell products co-cultured with Emulate's induced brain microvascular endothelial cells, providing a platform that models the complexities of the human brain. Credit: Emulate</media:description>
      </media:content>
    </item>
    <item>
      <title>Customed raises funds for platform to transform orthopedic surgery</title>
      <description>
        <![CDATA[Customed Ltd. has completed its seed funding round, bringing the total capital raised to $6 million. The company has developed a platform which provides orthopedic surgeons with personalized pre-surgical planning and 3D printed surgical tools. The funds will be used to support regulatory approvals in the U.S. and EU, as well as expansion into additional automated orthopedic indications.]]>
      </description>
      <guid>http://www.bioworld.com/articles/725462</guid>
      <pubDate>Thu, 30 Oct 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/725462-customed-raises-funds-for-platform-to-transform-orthopedic-surgery</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/CustoMED-software-10-30.webp?t=1761859346" type="image/jpeg" medium="image" fileSize="192480">
        <media:title type="plain">Customed software </media:title>
        <media:description type="plain">Customed software provides orthopedic surgeons with personalized pre-surgical planning and 3D printed surgical tools. Credit: Customed Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>Researchers find that 3D-printed tissues could help repair brain injuries</title>
      <description>
        <![CDATA[Researchers have for the first time used human neural stem cells to print 3D brain tissues that mimic the architecture of the brain’s outer layer, the cerebral cortex. This breakthrough technique, developed by a team from the U.K.’s University of Oxford, could one day be used to provide tailored repairs to the millions of people who suffer from severe brain injuries, for which there is no effective treatment.]]>
      </description>
      <guid>http://www.bioworld.com/articles/702828</guid>
      <pubDate>Tue, 14 Nov 2023 08:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/702828-researchers-find-that-3d-printed-tissues-could-help-repair-brain-injuries</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/Brain-illustration.webp?t=1591647441" type="image/png" medium="image" fileSize="423792">
        <media:title type="plain">Brain illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Researchers find that 3D-printed tissues could help repair brain injuries</title>
      <description>
        <![CDATA[Researchers have for the first time used human neural stem cells to print 3D brain tissues that mimic the architecture of the brain’s outer layer, the cerebral cortex. This breakthrough technique, developed by a team from the U.K.’s University of Oxford, could one day be used to provide tailored repairs to the millions of people who suffer from severe brain injuries, for which there is no effective treatment.
]]>
      </description>
      <guid>http://www.bioworld.com/articles/701797</guid>
      <pubDate>Wed, 18 Oct 2023 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/701797-researchers-find-that-3d-printed-tissues-could-help-repair-brain-injuries</link>
    </item>
    <item>
      <title>Conformis and Restor3d agree to merge </title>
      <description>
        <![CDATA[Conformis Inc. has inked a definitive agreement to be acquired by Restor3d Inc., in a move that could potentially create a formidable presence in the personalized orthopedics space. Under the agreement, Restor3d will acquire all outstanding shares of Conformis common stock (NYSE:CFMS) at $2.27 per share in cash. The purchase price represents a roughly 96% premium to Conformis’ closing price on June 22, 2023.]]>
      </description>
      <guid>http://www.bioworld.com/articles/698464</guid>
      <pubDate>Wed, 28 Jun 2023 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/698464-conformis-and-restor3d-agree-to-merge</link>
    </item>
    <item>
      <title>Singular Health joins JV for East Asia expansion of its 3D software, printing solutions</title>
      <description>
        <![CDATA[Singular Health Group Ltd. entered a 50-50 joint venture in Macau that will explore the potential of Singular’s Scan to Surgery software for the East Asian market, which the company has long seen as a key opportunity for its 3D software and medical 3D printing ambitions.]]>
      </description>
      <guid>http://www.bioworld.com/articles/516764</guid>
      <pubDate>Tue, 08 Mar 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/516764-singular-health-joins-jv-for-east-asia-expansion-of-its-3d-software-printing-solutions</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2022/03-08-Singular-Health-colorization-tool.webp?t=1646779358" type="image/png" medium="image" fileSize="718513">
        <media:title type="plain">3d-colored head and neck muscle anatomy</media:title>
        <media:description type="plain">Singular Health’s 3D colorization tool for cranium implants. Credit: Singular Health Group Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>Georgia Tech 3D-printed splint to sub for missing windpipe in newborns</title>
      <description>
        <![CDATA[Engineers at Atlanta-based Georgia Tech’s Center for 3D Medical Fabrication have developed a 3D-printed tracheal splint as an airway for children born with a rare condition known as tracheal agenesis or the absence of a trachea or windpipe.]]>
      </description>
      <guid>http://www.bioworld.com/articles/516232</guid>
      <pubDate>Fri, 18 Feb 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/516232-georgia-tech-3d-printed-splint-to-sub-for-missing-windpipe-in-newborns</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2022/02-18-GT-3d-printed-tracheal-splint.webp?t=1645223675" type="image/png" medium="image" fileSize="123622">
        <media:title type="plain">Rendering of splint on trachea</media:title>
        <media:description type="plain">Model of Georgia Tech’s trachea splint for reconstruction of airway in baby born without a windpipe.</media:description>
      </media:content>
    </item>
    <item>
      <title>Collplant taps Cellink to explore regenerative breast implant production </title>
      <description>
        <![CDATA[Collplant Biotechnologies Ltd. has signed a collaboration agreement with 3D bioprinting company Cellink AB for future commercial production of regenerative breast implants. Rehovot, Israel-based Collplant has developed prototypes of 3D bioprinted implants and is evaluating them in preclinical studies. The regenerative implants are designed to degrade over time and be replaced by new, naturally grown breast tissue. The technology aims to overcome the challenges of existing breast procedures that use silicone implants or autologous fat tissue transfer.]]>
      </description>
      <guid>http://www.bioworld.com/articles/516139</guid>
      <pubDate>Wed, 16 Feb 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/516139-collplant-taps-cellink-to-explore-regenerative-breast-implant-production</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Deals-handshake-analysis-illustration.webp?t=1614643337" type="image/png" medium="image" fileSize="1213840">
        <media:title type="plain">Concept of business partnership</media:title>
      </media:content>
    </item>
    <item>
      <title>Healshape developing 3D-printed breast bioprosthesis using patients’ own cells</title>
      <description>
        <![CDATA[PARIS – Healshape SAS is preparing a $6.8 million series A round to develop a 3D bioprinted breast implant obtained from the patients' own cells. Supported by Pulsalys SAS, Lyon Saint-Etienne’s technology transfer acceleration company, this startup from Villeurbanne, France, has already benefited from more than a million dollars of French public funding and subsidies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/515232</guid>
      <pubDate>Tue, 18 Jan 2022 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/515232-healshape-developing-3d-printed-breast-bioprosthesis-using-patients-own-cells</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2022/01-18-Healshape.webp?t=1642548070" type="image/png" medium="image" fileSize="1447030">
        <media:title type="plain">Healshape's breast bioprosthesis being 3D printed </media:title>
        <media:description type="plain">Breast implant produced by 3D printing techniques from cells taken from the patient before the operation. Credit: Healshape</media:description>
      </media:content>
    </item>
    <item>
      <title>Bellaseno publishes results from study on its Senella soft tissue reconstruction scaffold</title>
      <description>
        <![CDATA[PARIS – Bellaseno GmbH reported publication of first-in-human data for its 3D-printed biodegradable and highly porous Senella scaffold filled with autologous fat graft to correct a chest deformation in a 22-year-old patient with severe pectus excavatum. The article was published in the <em>European Journal of Plastic Surgery</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514600</guid>
      <pubDate>Mon, 27 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514600-bellaseno-publishes-results-from-study-on-its-senella-soft-tissue-reconstruction-scaffold</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/12-27-Bellaseno-Senella.webp?t=1640642703" type="image/png" medium="image" fileSize="575532">
        <media:title type="plain">The Senella absorbable soft tissue reconstruction scaffold</media:title>
        <media:description type="plain">The Senella absorbable soft-tissue reconstruction scaffold for orthopedic reconstructive surgery. Credit: Bellaseno GmbH.</media:description>
      </media:content>
    </item>
    <item>
      <title>Questions abound in FDA discussion paper for 3D POC manufacturing</title>
      <description>
        <![CDATA[At long last, the FDA has released information on a potential regulatory framework for 3D device printing at the point of care (POC), just the first step in the implicit guidance development process. The document highlights several potential tripwires for device manufacturers and operators of health care facilities, but the large number of complex questions posed by the paper suggests that a final guidance is not likely to arrive any time soon.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514221</guid>
      <pubDate>Mon, 13 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514221-questions-abound-in-fda-discussion-paper-for-3d-poc-manufacturing</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/3d-printing.webp?t=1589384823" type="image/png" medium="image" fileSize="490231">
        <media:title type="plain">3D printing illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Med-tech innovations selected for The Royal Academy of Engineering’s LIF Advance program</title>
      <description>
        <![CDATA[The Royal Academy of Engineering in the U.K. has selected 15 entrepreneurs from seven different countries for the latest edition of its Leaders in Innovation Fellowships Advance (LIF Advance) program, including some that offer med-tech solutions.]]>
      </description>
      <guid>http://www.bioworld.com/articles/514002</guid>
      <pubDate>Mon, 06 Dec 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/514002-med-tech-innovations-selected-for-the-royal-academy-of-engineerings-lif-advance-program</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/newco-idea-hand-holding-lighbulb.webp?t=1588277852" type="image/png" medium="image" fileSize="376409">
        <media:title type="plain">Hand holding lightbulb</media:title>
      </media:content>
    </item>
    <item>
      <title>Bone 3D, Stratasys partner to deploy 3D printing across French hospitals</title>
      <description>
        <![CDATA[PARIS – Bone 3D SAS has signed a partnership with Stratasys Ltd. to put 3D printing technology directly into the hands of all 3,000 French hospitals and their front-line medical professionals. This new service, called Hospifactory, makes it possible to leverage additive manufacturing to produce medical equipment and devices directly on site at the hospital.]]>
      </description>
      <guid>http://www.bioworld.com/articles/513438</guid>
      <pubDate>Tue, 16 Nov 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/513438-bone-3d-stratasys-partner-to-deploy-3d-printing-across-french-hospitals</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/11-16-BONE-3D-hopital-Cochin.webp?t=1637102942" type="image/png" medium="image" fileSize="557384">
        <media:title type="plain">Stratasys 3D printers deployed at Hôpital Cochin</media:title>
        <media:description type="plain">Stratasys 3D printers deployed in a 150 m2 room at the Hôpital Cochin in Paris as part of Bone 3D's Hospifactory service.</media:description>
      </media:content>
    </item>
    <item>
      <title>3D Systems acquires Volumetric for up to $400M, expands organ bioprinting program</title>
      <description>
        <![CDATA[3D Systems Inc. acquired Volumetric Biotechnologies Inc. as part of its plan to expand its organ bioprinting program. The deal entails a $45 million upfront payment with an additional $355 million linked to meeting milestones “planned between now and 2035, and aligned with key points in the development process,” Volumetric President and CEO Jeffrey Graves told <em>BioWorld</em>. Houston-based Volumetric has focused on building replacement organs through bioprinting and created an approach that produces complex vasculature using light-based bioprinting.]]>
      </description>
      <guid>http://www.bioworld.com/articles/512895</guid>
      <pubDate>Fri, 29 Oct 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/512895-3d-systems-acquires-volumetric-for-up-to-400m-expands-organ-bioprinting-program</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/10-29-3d-systems-omg-lobep.webp?t=1635543801" type="image/png" medium="image" fileSize="634483">
        <media:title type="plain">Image of human vasculature model</media:title>
        <media:description type="plain">Human vasculature model created using Print to Perfusion process. Credit: United Therapeutics</media:description>
      </media:content>
    </item>
    <item>
      <title>Singular Health teams up with CSIRO, Osteopore on AI-based patient-specific cranial implants </title>
      <description>
        <![CDATA[PERTH, Australia – Singular Health Group Ltd. was awarded AU$50,000 (US$37,000) in funding from Australia’s Commonwealth Scientific and Industrial Research Organization’s (CSIRO) Kick-Start program to undertake a research project to develop artificial intelligence (AI)-based tools to automatically design patient-specific cranial implants. The AI will be integrated into Singular Health’s surgical planning software for editing before the cranial implants are 3D printed.]]>
      </description>
      <guid>http://www.bioworld.com/articles/512803</guid>
      <pubDate>Wed, 27 Oct 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/512803-singular-health-teams-up-with-csiro-osteopore-on-ai-based-patient-specific-cranial-implants</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/10-27-Singular-Health-spinal-spacers.webp?t=1635371877" type="image/png" medium="image" fileSize="104842">
        <media:title type="plain">A model of a 3D segmented scoliosis spine </media:title>
        <media:description type="plain">Singular Health previously worked with CSIRO to develop a spinal segmentation model that could be integrated into Singular’s 3Dicom virtual surgical planning software. Credit: Singular Health Group Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>4D Biomaterials raises £1.6M to develop soft tissue repair biopolymer</title>
      <description>
        <![CDATA[LONDON – Birmingham University spinout 4D Biomaterials Ltd. has raised initial funding of £1.6 million (US$2.2 million) to commercialize a new shape-changing biopolymer for use in soft tissue repair.]]>
      </description>
      <guid>http://www.bioworld.com/articles/510152</guid>
      <pubDate>Thu, 05 Aug 2021 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/510152-d-biomaterials-raises-16m-to-develop-soft-tissue-repair-biopolymer</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/British-pound.webp?t=1599766050" type="image/png" medium="image" fileSize="509714">
        <media:title type="plain">British pound</media:title>
      </media:content>
    </item>
    <item>
      <title>Australian researchers outsmart 3D printers by printing biomaterials in empty space</title>
      <description>
        <![CDATA[PERTH, Australia &ndash; Researchers at RMIT University and St. Vincent&#39;s Hospital in Melbourne have flipped traditional 3D printing to create more intricate biomedical structures, advancing new technologies for regrowing bones and tissue. Instead of making the bioscaffolds directly, the team 3D printed molds with intricately patterned cavities and then filled them with biocompatible materials, before dissolving the molds away.]]>
      </description>
      <guid>http://www.bioworld.com/articles/508666</guid>
      <pubDate>Fri, 25 Jun 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/508666-australian-researchers-outsmart-3d-printers-by-printing-biomaterials-in-empty-space</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/06-25-3D-RMIT-bioscaffold.webp?t=1624647706" type="image/png" medium="image" fileSize="545326">
        <media:title type="plain">Tiny 3D-printed bioscaffold on gloved finger</media:title>
        <media:description type="plain">An intricate biomedical structure created with the new Negative Embodied Sacrificial Template 3D technique. Credit: RMIT University</media:description>
      </media:content>
    </item>
    <item>
      <title>New AI-driven, 3D-designed, customized pessary may be a better fit</title>
      <description>
        <![CDATA[TORONTO &ndash; Femtherapeutics Inc. is combining artificial intelligence-driven machine learning and 3D design to manufacture a device for relieving urinary incontinence and discomfort in women suffering pelvic organ prolapse. The custom-made pessary is intended to support vaginal tissues displaced because of the condition, replacing conventional pessaries that company officials said can result in irritation and penetrate soft tissues causing bleeding.]]>
      </description>
      <guid>http://www.bioworld.com/articles/508581</guid>
      <pubDate>Wed, 23 Jun 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/508581-new-ai-driven-3d-designed-customized-pessary-may-be-a-better-fit</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/06-23-Femtherapeutics-3D-models.webp?t=1624477314" type="image/png" medium="image" fileSize="573306">
        <media:title type="plain">Renderings of Pessaries in different shapes</media:title>
        <media:description type="plain">Femtherapeutics trains its AI software models to collate data from the patient population with the individual patient’s data to produce a pessary more conducive to a woman’s vaginal anatomy.</media:description>
      </media:content>
    </item>
    <item>
      <title>New 3D printing process to tailor-make medical devices combats bacterial resistance</title>
      <description>
        <![CDATA[A new 3D printing technique has allowed University of Nottingham researchers to tailor-make artificial body parts and other medical devices that are both implantable and bacteria-resistant. The multi-materials manufactured in the study were also adapted to 3D printing technology that is able to offer devices that can better meet the need of the patient and minimize the surgeries led by device failure that increase the risk of infections.]]>
      </description>
      <guid>http://www.bioworld.com/articles/508257</guid>
      <pubDate>Tue, 15 Jun 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/508257-new-3d-printing-process-to-tailor-make-medical-devices-combats-bacterial-resistance</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/3d-printing.webp?t=1589384823" type="image/png" medium="image" fileSize="490231">
        <media:title type="plain">3D printing illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>TGA finetunes regulatory framework for custom-made, 3D-printed devices</title>
      <description>
        <![CDATA[PERTH, Australia &ndash; After unveiling its new regulatory framework for custom-made and 3D-printed devices, Australia&rsquo;s Therapeutic Goods Administration (TGA) is now proposing further refinements due to pushbacks from stakeholder that manufacture custom-made and patient-matched devices.]]>
      </description>
      <guid>http://www.bioworld.com/articles/508125</guid>
      <pubDate>Fri, 11 Jun 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/508125-tga-finetunes-regulatory-framework-for-custom-made-3d-printed-devices</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Australia/australia-flag-country.webp?t=1591995441" type="image/png" medium="image" fileSize="1000519">
        <media:title type="plain">Australia map, flag</media:title>
      </media:content>
    </item>
    <item>
      <title>Kinos and Restor3d merge to step up their presence in the foot and ankle market</title>
      <description>
        <![CDATA[Restor3d Inc. added a new dimension to its offerings with its merger with Kinos Medical Inc. The combination will increase Restor3d&rsquo;s presence in the foot and ankle repair and replacement market by adding the Kinos Axiom total ankle system to its portfolio of 3D-printed implants using biomedical materials in a variety of applications.]]>
      </description>
      <guid>http://www.bioworld.com/articles/507165</guid>
      <pubDate>Mon, 17 May 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/507165-kinos-and-restor3d-merge-to-step-up-their-presence-in-the-foot-and-ankle-market</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/05-17-Kinos-Axiom.webp?t=1621289006" type="image/png" medium="image" fileSize="247225">
        <media:title type="plain">Axios device image</media:title>
        <media:description type="plain">Axiom total ankle system Credit: Kinos Medical Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Readily3d awarded EU funding to develop miniature pancreas using its 3D bioprinting techniques</title>
      <description>
        <![CDATA[PARIS &ndash; Readily3d SA has been awarded just under $600k by the European Union to develop a living model of the pancreas using its Tomolite 3D bioprinting technique. The European program, Enlight, boasts a total budget of $4.4 million provided by the European Innovation Fund 2020.]]>
      </description>
      <guid>http://www.bioworld.com/articles/507159</guid>
      <pubDate>Mon, 17 May 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/507159-readily3d-awarded-eu-funding-to-develop-miniature-pancreas-using-its-3d-bioprinting-techniques</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/05-17-Readily3d-Co-founders-Tomolite.webp?t=1621287704" type="image/png" medium="image" fileSize="1266834">
        <media:title type="plain">The three co-founders of Readily3d standing with the Tomolite printer</media:title>
        <media:description type="plain">The three co-founders of Readily3d (right to left): Damien Loterie, CEO; Christophe Moser, advisor; and Paul Delrot, CTO.</media:description>
      </media:content>
    </item>
    <item>
      <title>Neo-Bionica brings together precision engineering with in-house manufacturing capability</title>
      <description>
        <![CDATA[PERTH, Australia &ndash; The launch of Australia&rsquo;s first medical device development and manufacturing facility in Melbourne is set to fast-track new treatments for people with conditions such as epilepsy, Parkinson&rsquo;s disease, hearing loss, stroke and diabetes.]]>
      </description>
      <guid>http://www.bioworld.com/articles/507108</guid>
      <pubDate>Fri, 14 May 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/507108-neo-bionica-brings-together-precision-engineering-with-in-house-manufacturing-capability</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/05-14-Neo-Bionica-device-electrode.webp?t=1621020025" type="image/png" medium="image" fileSize="1203958">
        <media:title type="plain">Closeup of researcher holding electrode</media:title>
        <media:description type="plain">Medical device electrode created at the Bionics Institute.</media:description>
      </media:content>
    </item>
    <item>
      <title>Additive manufacturing still a niche player despite considerable headway in med tech</title>
      <description>
        <![CDATA[Additive manufacturing, often referred to as 3D printing, has evolved considerably over the past few decades, and plays a significant role in the world of orthopedic devices. Despite numerous technological advances, additive manufacturing (AM) still accounts for a small share of the device market and may never overwhelm traditional manufacturing for the med-tech industry due to a number of limitations.]]>
      </description>
      <guid>http://www.bioworld.com/articles/507082</guid>
      <pubDate>Thu, 13 May 2021 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/507082-additive-manufacturing-still-a-niche-player-despite-considerable-headway-in-med-tech</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/3d-printing.webp?t=1589384823" type="image/png" medium="image" fileSize="490231">
        <media:title type="plain">3D printing illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Blue Ocean Spine wins investment backing from SHS</title>
      <description>
        <![CDATA[Blue Ocean Spine GmbH has won a major investment from SHS GmbH, also from Tuttlingen in Germany, to develop its next-generation functional spinal implant. The two companies are declining to disclose the size of the series A investment.]]>
      </description>
      <guid>http://www.bioworld.com/articles/503663</guid>
      <pubDate>Tue, 16 Feb 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/503663-blue-ocean-spine-wins-investment-backing-from-shs</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/02-16-Blue-Ocean-Cage.webp?t=1613516614" type="image/png" medium="image" fileSize="452038">
        <media:title type="plain">Device image</media:title>
        <media:description type="plain">3D-printed intervertebral disc spacer, or spinal cage. Credit: Blue Ocean Spine GmbH</media:description>
      </media:content>
    </item>
    <item>
      <title>Solvay partners with Printerprezz to develop 3D printing solutions for medical devices</title>
      <description>
        <![CDATA[PARIS &ndash; Solvay SA is partnering with Printerprezz Inc. to develop 3D printing technology using Selective Laser Sintering (SLS) for implants and other medical devices. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/502002</guid>
      <pubDate>Mon, 04 Jan 2021 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/502002-solvay-partners-with-printerprezz-to-develop-3d-printing-solutions-for-medical-devices</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Devices/3d-printing.webp?t=1589384823" type="image/png" medium="image" fileSize="490231">
        <media:title type="plain">3D printing illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Australia unveils new framework for personalized medical devices, 3D-printed devices</title>
      <description>
        <![CDATA[PERTH, Australia &ndash; Australia&rsquo;s Therapeutic Good Administration (TGA) has unveiled its final regulatory requirements for personalized medical devices, including 3D-printed devices, that go into effect on Feb. 25, 2021. Under the previous framework, custom-made medical devices were exempt from the requirement to be included in the Australian Register of Therapeutic Goods (ARTG).]]>
      </description>
      <guid>http://www.bioworld.com/articles/500872</guid>
      <pubDate>Wed, 02 Dec 2020 13:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/500872-australia-unveils-new-framework-for-personalized-medical-devices-3d-printed-devices</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Geographic-regions/Australia/australia-flag-country.webp?t=1591995441" type="image/png" medium="image" fileSize="1000519">
        <media:title type="plain">Australia map, flag</media:title>
      </media:content>
    </item>
    <item>
      <title>Wellcome Leap kicks off its funding with $50M to develop human organs</title>
      <description>
        <![CDATA[Wellcome Leap has launched its first program, dedicating $50 million to help develop human tissues, organoids and full organs. The Human Organs, Physiology and Engineering (HOPE) program is looking to bring biologists and engineers together to develop both therapeutic organs as well as organs that can be used in vitro to help discover and develop new medications.]]>
      </description>
      <guid>http://www.bioworld.com/articles/499963</guid>
      <pubDate>Mon, 09 Nov 2020 12:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/499963-wellcome-leap-kicks-off-its-funding-with-50m-to-develop-human-organs</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2020/Nov-2020/Aspect-Biosystems-11-9.webp?t=1604963364" type="image/png" medium="image" fileSize="561860">
        <media:title type="plain">3D bioprinting technology</media:title>
        <media:description type="plain">3D bioprinting. Credit: Aspect Biosystems Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>Mid-air, 3D medical modeling gets lift from Canadian and Swiss-based firms</title>
      <description>
        <![CDATA[TORONTO &ndash; Virtual reality (VR) platform developer Realize Medical Inc. is collaborating with Lausanne, Switzerland&rsquo;s Logitech International SA on what the Ottawa-based med tech calls &ldquo;the world&rsquo;s first VR platform for creating patient-specific 3D medical models.&rdquo; ]]>
      </description>
      <guid>http://www.bioworld.com/articles/496812</guid>
      <pubDate>Tue, 18 Aug 2020 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/496812-mid-air-3d-medical-modeling-gets-lift-from-canadian-and-swiss-based-firms</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/8-18-Elucis-VR-stylus.webp?t=1597787648" type="image/png" medium="image" fileSize="613329">
        <media:title type="plain">Visualization of the Elucis platform and Logitech stylus </media:title>
        <media:description type="plain">Logitech's stylus lets you mark up a 2D image within the Elucis VR environment and then edit the 3D model freehand in space. Credit: Realize Medical Inc.</media:description>
      </media:content>
    </item>
  </channel>
</rss>
